Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis.

Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis.

Item
http://www.wikidata.org/entity/Q38007853
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantationMycophenolate mofetil versus methotrexate for prevention of acute graft-versus-host disease in patients receiving allogeneic hematopoietic stem cell transplantationCARs in chronic lymphocytic leukemia -- ready to driveRole of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a reviewManaging high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia.Predictors of outcome in reduced intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: summarizing the evidence and highlighting the limitations.Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations.Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
P2860

Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis.

Item
http://www.wikidata.org/entity/Q38007853
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Comparing efficacy of reduced- ...... L: a Markov decision analysis.
@en
type
label
Comparing efficacy of reduced- ...... L: a Markov decision analysis.
@en
prefLabel
Comparing efficacy of reduced- ...... L: a Markov decision analysis.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Comparing efficacy of reduced- ...... L: a Markov decision analysis.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698